Literature DB >> 26895960

Cancer Cell-derived Exosomes Induce Mitogen-activated Protein Kinase-dependent Monocyte Survival by Transport of Functional Receptor Tyrosine Kinases.

Xiao Song1, Yanping Ding1, Gang Liu1, Xiao Yang2, Ruifang Zhao1, Yinlong Zhang2, Xiao Zhao3, Gregory J Anderson4, Guangjun Nie5.   

Abstract

Tumor-associated macrophages (TAM) play pivotal roles in cancer initiation and progression. Monocytes, the precursors of TAMs, normally undergo spontaneous apoptosis within 2 days, but can subsist in the inflammatory tumor microenvironment for continuous survival and generation of sufficient TAMs. The mechanisms underlying tumor-driving monocyte survival remain obscure. Here we report that cancer cell-derived exosomes were crucial mediators for monocyte survival in the inflammatory niche. Analysis of the survival-promoting molecules in monocytes revealed that cancer cell-derived exosomes activated Ras and extracellular signal-regulated kinases in the mitogen-activated protein kinase (MAPK) pathway, resulting in the prevention of caspase cleavage. Phosphorylated receptor tyrosine kinases (RTKs), such as phosphorylated epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER-2), were abundantly expressed in cancer cell-derived exosomes. Knock-out of EGFR or/and HER-2, or alternatively, inhibitors against their phosphorylation significantly disturbed the exosome-mediated activation of the MAPK pathway, inhibition of caspase cleavage, and increase in survival rate in monocytes. Moreover, the deprived survival-stimulating activity of exosomes due to null expression of EGFR and HER-2 could be restored by activation of another RTK, insulin receptor. Overall, our study uncovered a mechanism of tumor-associated monocyte survival and demonstrated that cancer cell-derived exosomes can stimulate the MAPK pathway in monocytes through transport of functional RTKs, leading to inactivation of apoptosis-related caspases. This work provides insights into the long sought question on monocyte survival prior to formation of plentiful TAMs in the tumor microenvironment.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  caspase; exosome (vesicle); mitogen-activated protein kinase (MAPK); monocyte; receptor tyrosine kinase; survival; tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 26895960      PMCID: PMC4861419          DOI: 10.1074/jbc.M116.716316

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  A role for the exosome in the in vivo degradation of unstable mRNAs.

Authors:  Simon Haile; Antonio M Estevez; Christine Clayton
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

2.  IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes.

Authors:  D F Mangan; B Robertson; S M Wahl
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

3.  Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures.

Authors:  S Becker; M K Warren; S Haskill
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

4.  Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.

Authors:  M K Warren; P Ralph
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

5.  Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages.

Authors:  R A Musson; H Shafran; P M Henson
Journal:  J Reticuloendothel Soc       Date:  1980-09

6.  Lipopolysaccharide (LPS) modulation of human monocyte accessory cell function in promoting T-cell colonies: inability of LPS and IL-1 to abrogate the need for monocytes with high HLA-DR expression.

Authors:  N D Tsakalos; L B Lachman; Y G Newhouse; R L Whisler
Journal:  Cell Immunol       Date:  1984-02       Impact factor: 4.868

7.  Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.

Authors:  T Spivak-Kroizman; D Rotin; D Pinchasi; A Ullrich; J Schlessinger; I Lax
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

8.  T cell receptor antagonist peptides induce positive selection.

Authors:  K A Hogquist; S C Jameson; W R Heath; J L Howard; M J Bevan; F R Carbone
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

9.  Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes.

Authors:  D F Mangan; G R Welch; S M Wahl
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

10.  An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein.

Authors:  J J Pink; S Y Jiang; M Fritsch; V C Jordan
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

View more
  37 in total

Review 1.  Ras and exosome signaling.

Authors:  Rachel E Sexton; Gabriel Mpilla; Steve Kim; Philip A Philip; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2019-02-12       Impact factor: 15.707

2.  Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.

Authors:  Enis Kostallari; Petra Hirsova; Alena Prasnicka; Vikas K Verma; Usman Yaqoob; Nicha Wongjarupong; Lewis R Roberts; Vijay H Shah
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

Review 3.  The key role of extracellular vesicles in the metastatic process.

Authors:  Hongyun Zhao; Abhinav Achreja; Elisabetta Iessi; Mariantonia Logozzi; Davide Mizzoni; Rossella Di Raimo; Deepak Nagrath; Stefano Fais
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-24       Impact factor: 10.680

Review 4.  The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].

Authors:  Vignesh Sundararajan; Fazlul H Sarkar; Thamil Selvee Ramasamy
Journal:  Cell Oncol (Dordr)       Date:  2018-04-17       Impact factor: 6.730

Review 5.  Monocyte Regulation in Homeostasis and Malignancy.

Authors:  Amy Robinson; Claudia Z Han; Christopher K Glass; Jeffrey W Pollard
Journal:  Trends Immunol       Date:  2021-01-11       Impact factor: 16.687

Review 6.  Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.

Authors:  Jiangdong Qiu; Gang Yang; Mengyu Feng; Suli Zheng; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

Review 7.  Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.

Authors:  Wuzhen Chen; Jingxin Jiang; Wenjie Xia; Jian Huang
Journal:  J Immunol Res       Date:  2017-05-31       Impact factor: 4.818

8.  Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK.

Authors:  Girijesh Kumar Patel; Mohammad Aslam Khan; Arun Bhardwaj; Sanjeev K Srivastava; Haseeb Zubair; Mary C Patton; Seema Singh; Moh'd Khushman; Ajay P Singh
Journal:  Br J Cancer       Date:  2017-02-02       Impact factor: 7.640

Review 9.  How cancer cells dictate their microenvironment: present roles of extracellular vesicles.

Authors:  Yutaka Naito; Yusuke Yoshioka; Yusuke Yamamoto; Takahiro Ochiya
Journal:  Cell Mol Life Sci       Date:  2016-08-31       Impact factor: 9.261

10.  MiR-101 inhibits ovarian carcinogenesis by repressing the expression of brain-derived neurotrophic factor.

Authors:  Ying Xu; Lei Xu; Jianbin Zheng; Lei Geng; Shuping Zhao
Journal:  FEBS Open Bio       Date:  2017-08-29       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.